Wang, S.-F.; Tsai, T.-T.; Li, Y.-D.; Chiu, P.-Y.; Hsieh, M.-K.; Liao, J.-C.; Lai, P.-L.; Kao, F.-C.
Percutaneous Endoscopic Interbody Debridement and Fusion (PEIDF) Decreases Risk of Sepsis and Mortality in Treating Infectious Spondylodiscitis for Patients with Poor Physical Status, a Retrospective Cohort Study. Biomedicines 2022, 10, 1659.
https://doi.org/10.3390/biomedicines10071659
AMA Style
Wang S-F, Tsai T-T, Li Y-D, Chiu P-Y, Hsieh M-K, Liao J-C, Lai P-L, Kao F-C.
Percutaneous Endoscopic Interbody Debridement and Fusion (PEIDF) Decreases Risk of Sepsis and Mortality in Treating Infectious Spondylodiscitis for Patients with Poor Physical Status, a Retrospective Cohort Study. Biomedicines. 2022; 10(7):1659.
https://doi.org/10.3390/biomedicines10071659
Chicago/Turabian Style
Wang, Sheng-Fen, Tsung-Ting Tsai, Yun-Da Li, Ping-Yeh Chiu, Ming-Kai Hsieh, Jen-Chung Liao, Po-Liang Lai, and Fu-Cheng Kao.
2022. "Percutaneous Endoscopic Interbody Debridement and Fusion (PEIDF) Decreases Risk of Sepsis and Mortality in Treating Infectious Spondylodiscitis for Patients with Poor Physical Status, a Retrospective Cohort Study" Biomedicines 10, no. 7: 1659.
https://doi.org/10.3390/biomedicines10071659
APA Style
Wang, S.-F., Tsai, T.-T., Li, Y.-D., Chiu, P.-Y., Hsieh, M.-K., Liao, J.-C., Lai, P.-L., & Kao, F.-C.
(2022). Percutaneous Endoscopic Interbody Debridement and Fusion (PEIDF) Decreases Risk of Sepsis and Mortality in Treating Infectious Spondylodiscitis for Patients with Poor Physical Status, a Retrospective Cohort Study. Biomedicines, 10(7), 1659.
https://doi.org/10.3390/biomedicines10071659